MedX Health Expanded SkinSecure Reach in Europe
The skin measurement platform will now be represented by a new sales agent to support cosmetics and research.
Updated on Oct. 5, 2026 in Beauty

Live Poll
Do you trust that new skin measurement technologies provide more reliable evidence for cosmetic product claims?
MedX Health has appointed Monaderm as its European sales agent for SkinSecure, a cloud-based platform for skin research. The move aims to increase access to advanced skin-mapping technology within the European cosmetics and research sectors.
Why it matters
This partnership expands the availability of imaging tools designed to quantify skin metrics, which may accelerate the pace of dermatological and cosmetic research in the region.
SIAscopy technology, which powers the SkinSecure platform, has been adopted by more than 29 contract research organizations (CROs) and sponsors. The platform is designed to provide high-resolution skin data, though the extent of its real-world clinical adoption remains under observation.
The players
MedX Health
A medical device company based in Mississauga that develops high-resolution imaging technology for dermatological assessment.
Monaderm
A Monaco-based firm with 30 years of experience providing specialized instrumentation and measurement services to the skin industry.
The details
SkinSecure operates as a cloud-based platform that utilizes SIAscope multi-spectral imaging to capture data on collagen, melanin, and hemoglobin in living skin. A single measurement capture takes 30 seconds to complete, with the data then shared instantly across research sites to facilitate efficient study workflows. By appointing Monaderm, MedX Health seeks to leverage the firm’s three decades of industry experience to integrate this imaging capability into more European research projects.
Timeline
SkinSecure technology launched in July 2026.
Cosmetic 360 takes place in Paris on October 14-15, 2026.
Health Landscape
The adoption of cloud-based multi-spectral imaging represents a shift toward more objective, digitized metrics in dermatological research. This trend follows the historical reliance on subjective visual grading in cosmetic testing, now being replaced by standardized, rapid data capture.
These advances in skin-mapping technology primarily serve to increase the precision of research for new skincare products and dermatological treatments. While these tools are currently focused on institutional research, they underscore the growing role of high-resolution digital imaging in evaluating skin health.
The takeaway
Advanced imaging platforms are standardizing how researchers measure skin characteristics like collagen and melanin levels in real-time. If you are participating in a clinical trial or using a specialized skin treatment, consider asking your physician about the diagnostic methods being used to monitor your results.
Further reading
For more on the latest research-backed dermatological tools, explore our Beauty archive.
Live Poll
Do you trust that new skin measurement technologies provide more reliable evidence for cosmetic product claims?






